Date(s) - 3 Oct 2019 until 3 Oct 2019
6:00 PM - 9:00 PM
Arizona Science Center
Innovator and Investor Reception at Arizona Science Center
The Cavendish Community and Arizona’s Life Science Innovation Community will come together on October 3, 2019 at the Arizona Science Center for an evening under the stars from 6 – 9 PM hosted by Arizona Science Center, Cavendish Global and AZBio.
Join us for networking, refreshments, planetarium shows, entertainment, and the opportunity to explore Arizona Science Center exhibits.
Cavendish Global is a peer-to-peer community of paradigm-changing innovators in health and the life sciences; over 200 leading family offices, philanthropists, and investors.
Date: Thursday, October 3, 2019
Time: 6-9 pm
Location: Arizona Science Center, 600 E Washington St, Phoenix, AZ 85004
Parking is recommended at the Heritage Square Garage, 501 E Monroe St, Phoenix, AZ 85004
Business attire is recommended.
This private reception is is designed to connect the Cavendish Community of impact investors and innovators with Arizona’s life science community.
Registration is complimentary. (Registration is limited.)
This reception is appropriate for:
- Life Science Innovators (Academic and Industry)
- Life Science and Healthcare Leaders
- Elected Leaders*
- Accredited Investors including Angels, Venture Capitalists, Family Offices, and Foundations
Note: Registered attendees for the The Cavendish Global – 2019 Phoenix BioHealth Impact Forum do not have to register again for this reception. The Cavendish Global team will register for you.
*Pursuant to AZBio Policy, all persons holding elected office, candidates for office, and members of Congressional Staff are
eligible for complimentary registration at any AZBio event in recognition of their service to the people of Arizona.
The Innovator and Investor Reception at Arizona Science Center is hosted by:
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. Formed through the merger of IMS Health and Quintiles, IQVIA applies human data science — leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science — to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes. Powered by the IQVIA CORE™, IQVIA delivers unique and actionable insights at the intersection of large-scale analytics, transformative technology and extensive domain expertise, as well as execution capabilities. With approximately 61,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.